Stocks
Funds
Screener
Sectors
Watchlists

Latest Qiming U.S. Ventures Management, LLC Stock Portfolio

About Qiming U.S. Ventures Management, LLC and 13F Hedge Fund Stock Holdings

In it's latest 13F Holdings report, QIMING U.S. VENTURES MANAGEMENT, LLC reported an equity portfolio of $55.6 Millions as of 30 Sep, 2025.

The top stock holdings of QIMING U.S. VENTURES MANAGEMENT, LLC are , , JSPR. The fund has invested 63.8% of it's portfolio in TOURMALINE BIO INC and 31.7% of portfolio in KORRO BIO INC.

The fund managers got completely rid off VENTYX BIOSCIENCES INC (VTYX) and HILLEVAX INC (HLVX) stocks.

Qiming U.S. Ventures Management, LLC Annual Return Estimates Vs S&P 500

New Buys

No new stocks were added by Qiming U.S. Ventures Management, LLC

Additions

No additions were made to existing positions by Qiming U.S. Ventures Management, LLC

Reductions

None of the existing positions were reduced by Qiming U.S. Ventures Management, LLC

Sold off

Ticker$ Sold
ventyx biosciences inc-882,162
hillevax inc-741,504

Qiming U.S. Ventures Management, LLC got rid off the above stocks

Sector Distribution

Sector%
Others95.4
Healthcare4.6

Market Cap. Distribution

Category%
UNALLOCATED95.4
MICRO-CAP4

Stocks belong to which Index?

Index%
Others99.4
Top 5 Winners (%)%
Top 5 Winners ($)$
Top 5 Losers (%)%
JSPR
jasper therapeutics inc
-57.1 %
KZR
kezar life sciences inc
-14.8 %
Top 5 Losers ($)$
JSPR
jasper therapeutics inc
-2.9 M
KZR
kezar life sciences inc
-0.1 M

Qiming U.S. Ventures Management, LLC Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of Qiming U.S. Ventures Management, LLC

Last Reported on: 10 Nov, 2025
TickerNamesorted ascending% PortfolioShares Held$ ValueType% ChangeOptions